A few decades ago, nobody really questioned vaccines. They were viewed as a standard part of staying healthy and safe. Today, the number of people questioning vaccines risks prolonging a pandemic that has already killed hundreds of thousands of Americans. How we got to this moment didn’t start with the rollout of vaccines or in March 2020, or even with the election of Donald Trump. Our confidence in vaccines, often isn't even about vaccines. It’s about trust. And that trust has been eroding for a long time. Doubt, a new series from Bloomberg’s Prognosis podcast, looks at the forces that have been breaking down that trust. We'll trace the rise of vaccine skepticism in America to show how we got here — and where we’re going. Doubt launches on March 23. Subscribe to Prognosis today on Apple Podcasts, Spotify or wherever you get your podcasts.
See omnystudio.com/listener for privacy information.
Amazon - The Everything Everything
Pandora Got Siriusly Outnegotiated
How Do You Value Blue Apron?
Toshiba Memory Chip Sale Hinges on Nationalism
The View From Europe
Abercrombie & Fitch Seeks Savior
The Strange Tale of Straight Path
Why Time + Meredith Couldn't Get Done
Spin The Telecom Wheel of Mergers
Amazon vs. Walmart
Going Beyond The M&A Headlines
TV Broadcasters Are Poised for Merger Spree
Akzo Nobel Fends Off PPG
Intel Buys Mobileye; What's Softbank's "Vision''?
Time's Up at Time Inc. as Board Ponders Bids
66: Should You Invest in Snap? A Debate!
65: What's Next for Kraft Heinz?
64: GM Exploring Sale of European Business
63: Is Verizon Planning a Megadeal?
62: AppDynamics Chooses Sale Over IPO
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Masters in Business
Odd Lots
Bloomberg Surveillance
Bloomberg Businessweek
Prognosis: Losing it